nodes	percent_of_prediction	percent_of_DWPC	metapath
Physostigmine—BCHE—Ramipril—type 2 diabetes mellitus	0.681	1	CbGbCtD
Physostigmine—Salivary hypersecretion—Gliclazide—type 2 diabetes mellitus	0.00511	0.0557	CcSEcCtD
Physostigmine—Bradycardia—Glimepiride—type 2 diabetes mellitus	0.00363	0.0396	CcSEcCtD
Physostigmine—Bradycardia—Bromocriptine—type 2 diabetes mellitus	0.00327	0.0357	CcSEcCtD
Physostigmine—Salivary hypersecretion—Ramipril—type 2 diabetes mellitus	0.00325	0.0355	CcSEcCtD
Physostigmine—Nausea—Miglitol—type 2 diabetes mellitus	0.00297	0.0324	CcSEcCtD
Physostigmine—Convulsion—Glimepiride—type 2 diabetes mellitus	0.00269	0.0294	CcSEcCtD
Physostigmine—Bradycardia—Gliclazide—type 2 diabetes mellitus	0.00269	0.0293	CcSEcCtD
Physostigmine—Nausea—Tolbutamide—type 2 diabetes mellitus	0.00267	0.0292	CcSEcCtD
Physostigmine—Vomiting—Chlorpropamide—type 2 diabetes mellitus	0.0026	0.0284	CcSEcCtD
Physostigmine—Vomiting—Acarbose—type 2 diabetes mellitus	0.0025	0.0273	CcSEcCtD
Physostigmine—Nausea—Chlorpropamide—type 2 diabetes mellitus	0.00243	0.0265	CcSEcCtD
Physostigmine—Nausea—Tolazamide—type 2 diabetes mellitus	0.00243	0.0265	CcSEcCtD
Physostigmine—Convulsion—Bromocriptine—type 2 diabetes mellitus	0.00243	0.0265	CcSEcCtD
Physostigmine—Vomiting—Nateglinide—type 2 diabetes mellitus	0.00241	0.0263	CcSEcCtD
Physostigmine—Nausea—Acarbose—type 2 diabetes mellitus	0.00234	0.0255	CcSEcCtD
Physostigmine—Nausea—Nateglinide—type 2 diabetes mellitus	0.00225	0.0246	CcSEcCtD
Physostigmine—Bradycardia—Metformin—type 2 diabetes mellitus	0.00225	0.0246	CcSEcCtD
Physostigmine—Convulsion—Glyburide—type 2 diabetes mellitus	0.00222	0.0242	CcSEcCtD
Physostigmine—Bradycardia—Irbesartan—type 2 diabetes mellitus	0.00212	0.0232	CcSEcCtD
Physostigmine—Vomiting—Repaglinide—type 2 diabetes mellitus	0.00209	0.0228	CcSEcCtD
Physostigmine—Convulsion—Gliclazide—type 2 diabetes mellitus	0.00199	0.0217	CcSEcCtD
Physostigmine—Nausea—Repaglinide—type 2 diabetes mellitus	0.00195	0.0213	CcSEcCtD
Physostigmine—Nausea—Rosiglitazone—type 2 diabetes mellitus	0.00184	0.0201	CcSEcCtD
Physostigmine—Convulsion—Orlistat—type 2 diabetes mellitus	0.00181	0.0197	CcSEcCtD
Physostigmine—Vomiting—Glipizide—type 2 diabetes mellitus	0.00173	0.0188	CcSEcCtD
Physostigmine—Nausea—Glipizide—type 2 diabetes mellitus	0.00161	0.0176	CcSEcCtD
Physostigmine—Vomiting—Glimepiride—type 2 diabetes mellitus	0.00161	0.0176	CcSEcCtD
Physostigmine—Vomiting—Sitagliptin—type 2 diabetes mellitus	0.00161	0.0175	CcSEcCtD
Physostigmine—Nausea—Glimepiride—type 2 diabetes mellitus	0.0015	0.0164	CcSEcCtD
Physostigmine—Nausea—Sitagliptin—type 2 diabetes mellitus	0.0015	0.0164	CcSEcCtD
Physostigmine—Vomiting—Bromocriptine—type 2 diabetes mellitus	0.00145	0.0159	CcSEcCtD
Physostigmine—Nausea—Bromocriptine—type 2 diabetes mellitus	0.00136	0.0148	CcSEcCtD
Physostigmine—Vomiting—Glyburide—type 2 diabetes mellitus	0.00133	0.0145	CcSEcCtD
Physostigmine—Convulsion—Ramipril—type 2 diabetes mellitus	0.00127	0.0139	CcSEcCtD
Physostigmine—Nausea—Glyburide—type 2 diabetes mellitus	0.00124	0.0135	CcSEcCtD
Physostigmine—Vomiting—Gliclazide—type 2 diabetes mellitus	0.00119	0.013	CcSEcCtD
Physostigmine—Nausea—Gliclazide—type 2 diabetes mellitus	0.00111	0.0122	CcSEcCtD
Physostigmine—Vomiting—Valsartan—type 2 diabetes mellitus	0.0011	0.012	CcSEcCtD
Physostigmine—Vomiting—Orlistat—type 2 diabetes mellitus	0.00108	0.0118	CcSEcCtD
Physostigmine—Nausea—Valsartan—type 2 diabetes mellitus	0.00102	0.0112	CcSEcCtD
Physostigmine—Nausea—Orlistat—type 2 diabetes mellitus	0.00101	0.011	CcSEcCtD
Physostigmine—Vomiting—Metformin—type 2 diabetes mellitus	0.000998	0.0109	CcSEcCtD
Physostigmine—Vomiting—Irbesartan—type 2 diabetes mellitus	0.000942	0.0103	CcSEcCtD
Physostigmine—Nausea—Metformin—type 2 diabetes mellitus	0.000932	0.0102	CcSEcCtD
Physostigmine—Vomiting—Losartan—type 2 diabetes mellitus	0.000886	0.00967	CcSEcCtD
Physostigmine—Nausea—Irbesartan—type 2 diabetes mellitus	0.00088	0.0096	CcSEcCtD
Physostigmine—Nausea—Losartan—type 2 diabetes mellitus	0.000828	0.00904	CcSEcCtD
Physostigmine—Vomiting—Ramipril—type 2 diabetes mellitus	0.00076	0.0083	CcSEcCtD
Physostigmine—Nausea—Ramipril—type 2 diabetes mellitus	0.00071	0.00775	CcSEcCtD
Physostigmine—ACHE—Integrated Pancreatic Cancer Pathway—CASP8—type 2 diabetes mellitus	0.000312	0.00137	CbGpPWpGaD
Physostigmine—ACHE—Metabolism of lipids and lipoproteins—CPT1A—type 2 diabetes mellitus	0.000311	0.00136	CbGpPWpGaD
Physostigmine—ACHE—Metabolism—CDO1—type 2 diabetes mellitus	0.00031	0.00136	CbGpPWpGaD
Physostigmine—ACHE—Metabolism—GPD2—type 2 diabetes mellitus	0.00031	0.00136	CbGpPWpGaD
Physostigmine—ACHE—Integrated Pancreatic Cancer Pathway—IGF1—type 2 diabetes mellitus	0.000306	0.00135	CbGpPWpGaD
Physostigmine—ACHE—Metabolism of lipids and lipoproteins—LIPC—type 2 diabetes mellitus	0.000303	0.00133	CbGpPWpGaD
Physostigmine—ACHE—Metabolism of lipids and lipoproteins—CYP11A1—type 2 diabetes mellitus	0.000301	0.00132	CbGpPWpGaD
Physostigmine—BCHE—Transmission across Chemical Synapses—PRKCB—type 2 diabetes mellitus	0.000301	0.00132	CbGpPWpGaD
Physostigmine—ACHE—Metabolism—AK1—type 2 diabetes mellitus	0.000295	0.0013	CbGpPWpGaD
Physostigmine—ACHE—Metabolism of lipids and lipoproteins—CETP—type 2 diabetes mellitus	0.000292	0.00128	CbGpPWpGaD
Physostigmine—BCHE—Metabolism—AANAT—type 2 diabetes mellitus	0.000291	0.00128	CbGpPWpGaD
Physostigmine—BCHE—Metabolism—PTGDS—type 2 diabetes mellitus	0.000291	0.00128	CbGpPWpGaD
Physostigmine—BCHE—Neuronal System—ADCY5—type 2 diabetes mellitus	0.000285	0.00125	CbGpPWpGaD
Physostigmine—ACHE—Metabolism of proteins—ATF3—type 2 diabetes mellitus	0.000278	0.00122	CbGpPWpGaD
Physostigmine—BCHE—Metabolism of lipids and lipoproteins—CPT1A—type 2 diabetes mellitus	0.000277	0.00122	CbGpPWpGaD
Physostigmine—BCHE—Metabolism—CDO1—type 2 diabetes mellitus	0.000276	0.00121	CbGpPWpGaD
Physostigmine—BCHE—Metabolism—GPD2—type 2 diabetes mellitus	0.000276	0.00121	CbGpPWpGaD
Physostigmine—ACHE—Neuronal System—CALM1—type 2 diabetes mellitus	0.000275	0.00121	CbGpPWpGaD
Physostigmine—ACHE—Metabolism—SLC5A4—type 2 diabetes mellitus	0.000273	0.0012	CbGpPWpGaD
Physostigmine—ACHE—Metabolism—MAT1A—type 2 diabetes mellitus	0.000273	0.0012	CbGpPWpGaD
Physostigmine—ACHE—Metabolism of lipids and lipoproteins—SREBF1—type 2 diabetes mellitus	0.000271	0.00119	CbGpPWpGaD
Physostigmine—BCHE—Metabolism of lipids and lipoproteins—LIPC—type 2 diabetes mellitus	0.00027	0.00119	CbGpPWpGaD
Physostigmine—BCHE—Metabolism of lipids and lipoproteins—CYP11A1—type 2 diabetes mellitus	0.000268	0.00118	CbGpPWpGaD
Physostigmine—ACHE—Integrated Pancreatic Cancer Pathway—BCL2—type 2 diabetes mellitus	0.000267	0.00118	CbGpPWpGaD
Physostigmine—ACHE—Metabolism of lipids and lipoproteins—CTGF—type 2 diabetes mellitus	0.000266	0.00117	CbGpPWpGaD
Physostigmine—ACHE—Metabolism of lipids and lipoproteins—HMGCR—type 2 diabetes mellitus	0.000264	0.00116	CbGpPWpGaD
Physostigmine—BCHE—Metabolism—AK1—type 2 diabetes mellitus	0.000263	0.00116	CbGpPWpGaD
Physostigmine—ACHE—Metabolism—G6PC—type 2 diabetes mellitus	0.000263	0.00116	CbGpPWpGaD
Physostigmine—ACHE—Metabolism—HBA2—type 2 diabetes mellitus	0.000263	0.00116	CbGpPWpGaD
Physostigmine—ACHE—Metabolism—ENPP1—type 2 diabetes mellitus	0.000263	0.00116	CbGpPWpGaD
Physostigmine—ACHE—Metabolism—ND1—type 2 diabetes mellitus	0.000263	0.00116	CbGpPWpGaD
Physostigmine—ACHE—Metabolism—PPP1R3C—type 2 diabetes mellitus	0.000263	0.00116	CbGpPWpGaD
Physostigmine—BCHE—Metabolism of lipids and lipoproteins—CETP—type 2 diabetes mellitus	0.00026	0.00114	CbGpPWpGaD
Physostigmine—ACHE—Neuronal System—PRKCB—type 2 diabetes mellitus	0.000258	0.00113	CbGpPWpGaD
Physostigmine—ACHE—Metabolism—GCGR—type 2 diabetes mellitus	0.000255	0.00112	CbGpPWpGaD
Physostigmine—ACHE—Integrated Pancreatic Cancer Pathway—PTGS2—type 2 diabetes mellitus	0.000254	0.00112	CbGpPWpGaD
Physostigmine—ACHE—Metabolism of proteins—F7—type 2 diabetes mellitus	0.000249	0.0011	CbGpPWpGaD
Physostigmine—BCHE—Metabolism of proteins—ATF3—type 2 diabetes mellitus	0.000248	0.00109	CbGpPWpGaD
Physostigmine—ACHE—Metabolism of lipids and lipoproteins—CYP1A2—type 2 diabetes mellitus	0.000245	0.00108	CbGpPWpGaD
Physostigmine—BCHE—Neuronal System—CALM1—type 2 diabetes mellitus	0.000245	0.00108	CbGpPWpGaD
Physostigmine—BCHE—Metabolism—MAT1A—type 2 diabetes mellitus	0.000243	0.00107	CbGpPWpGaD
Physostigmine—BCHE—Metabolism—SLC5A4—type 2 diabetes mellitus	0.000243	0.00107	CbGpPWpGaD
Physostigmine—ACHE—Metabolism of proteins—PAX6—type 2 diabetes mellitus	0.000243	0.00107	CbGpPWpGaD
Physostigmine—BCHE—Metabolism of lipids and lipoproteins—SREBF1—type 2 diabetes mellitus	0.000242	0.00106	CbGpPWpGaD
Physostigmine—ACHE—Metabolism—OXCT1—type 2 diabetes mellitus	0.000241	0.00106	CbGpPWpGaD
Physostigmine—ACHE—Metabolism—CYTB—type 2 diabetes mellitus	0.000241	0.00106	CbGpPWpGaD
Physostigmine—BCHE—Metabolism of lipids and lipoproteins—CTGF—type 2 diabetes mellitus	0.000238	0.00104	CbGpPWpGaD
Physostigmine—ACHE—Integrated Pancreatic Cancer Pathway—CASP3—type 2 diabetes mellitus	0.000236	0.00104	CbGpPWpGaD
Physostigmine—BCHE—Metabolism of lipids and lipoproteins—HMGCR—type 2 diabetes mellitus	0.000236	0.00104	CbGpPWpGaD
Physostigmine—BCHE—Metabolism—HBA2—type 2 diabetes mellitus	0.000235	0.00103	CbGpPWpGaD
Physostigmine—BCHE—Metabolism—G6PC—type 2 diabetes mellitus	0.000235	0.00103	CbGpPWpGaD
Physostigmine—BCHE—Metabolism—ND1—type 2 diabetes mellitus	0.000235	0.00103	CbGpPWpGaD
Physostigmine—BCHE—Metabolism—PPP1R3C—type 2 diabetes mellitus	0.000235	0.00103	CbGpPWpGaD
Physostigmine—BCHE—Metabolism—ENPP1—type 2 diabetes mellitus	0.000235	0.00103	CbGpPWpGaD
Physostigmine—ACHE—Metabolism—SRD5A1—type 2 diabetes mellitus	0.000235	0.00103	CbGpPWpGaD
Physostigmine—BCHE—Neuronal System—PRKCB—type 2 diabetes mellitus	0.00023	0.00101	CbGpPWpGaD
Physostigmine—BCHE—Metabolism—GCGR—type 2 diabetes mellitus	0.000227	0.001	CbGpPWpGaD
Physostigmine—ACHE—Metabolism—ACACA—type 2 diabetes mellitus	0.000224	0.000984	CbGpPWpGaD
Physostigmine—ACHE—Metabolism—HSD17B3—type 2 diabetes mellitus	0.000224	0.000984	CbGpPWpGaD
Physostigmine—ACHE—Metabolism—STAR—type 2 diabetes mellitus	0.000224	0.000984	CbGpPWpGaD
Physostigmine—BCHE—Metabolism of proteins—F7—type 2 diabetes mellitus	0.000223	0.000978	CbGpPWpGaD
Physostigmine—ACHE—Metabolism of proteins—GHRL—type 2 diabetes mellitus	0.000222	0.000977	CbGpPWpGaD
Physostigmine—ACHE—Integrated Pancreatic Cancer Pathway—NFKB1—type 2 diabetes mellitus	0.00022	0.000969	CbGpPWpGaD
Physostigmine—BCHE—Metabolism of lipids and lipoproteins—CYP1A2—type 2 diabetes mellitus	0.000219	0.000962	CbGpPWpGaD
Physostigmine—BCHE—Metabolism of proteins—PAX6—type 2 diabetes mellitus	0.000217	0.000952	CbGpPWpGaD
Physostigmine—ACHE—Metabolism of proteins—ACE—type 2 diabetes mellitus	0.000215	0.000946	CbGpPWpGaD
Physostigmine—BCHE—Metabolism—CYTB—type 2 diabetes mellitus	0.000215	0.000944	CbGpPWpGaD
Physostigmine—BCHE—Metabolism—OXCT1—type 2 diabetes mellitus	0.000215	0.000944	CbGpPWpGaD
Physostigmine—ACHE—Metabolism—ABCC8—type 2 diabetes mellitus	0.000215	0.000943	CbGpPWpGaD
Physostigmine—ACHE—Metabolism—CBS—type 2 diabetes mellitus	0.000215	0.000943	CbGpPWpGaD
Physostigmine—BCHE—Metabolism—SRD5A1—type 2 diabetes mellitus	0.000209	0.00092	CbGpPWpGaD
Physostigmine—ACHE—Metabolism of proteins—TCF7L2—type 2 diabetes mellitus	0.000207	0.000909	CbGpPWpGaD
Physostigmine—ACHE—Metabolism—COX2—type 2 diabetes mellitus	0.000207	0.000908	CbGpPWpGaD
Physostigmine—ACHE—Metabolism—SLC5A2—type 2 diabetes mellitus	0.000207	0.000908	CbGpPWpGaD
Physostigmine—ACHE—Integrated Pancreatic Cancer Pathway—SRC—type 2 diabetes mellitus	0.000205	0.000903	CbGpPWpGaD
Physostigmine—ACHE—Metabolism of proteins—GCG—type 2 diabetes mellitus	0.000203	0.000894	CbGpPWpGaD
Physostigmine—ACHE—Metabolism—NCOA6—type 2 diabetes mellitus	0.000203	0.000892	CbGpPWpGaD
Physostigmine—ACHE—Metabolism of lipids and lipoproteins—PPARGC1A—type 2 diabetes mellitus	0.000203	0.000891	CbGpPWpGaD
Physostigmine—ACHE—Integrated Pancreatic Cancer Pathway—VEGFA—type 2 diabetes mellitus	0.0002	0.000879	CbGpPWpGaD
Physostigmine—BCHE—Metabolism—ACACA—type 2 diabetes mellitus	0.0002	0.000878	CbGpPWpGaD
Physostigmine—BCHE—Metabolism—HSD17B3—type 2 diabetes mellitus	0.0002	0.000878	CbGpPWpGaD
Physostigmine—BCHE—Metabolism—STAR—type 2 diabetes mellitus	0.0002	0.000878	CbGpPWpGaD
Physostigmine—ACHE—Metabolism—UCP3—type 2 diabetes mellitus	0.0002	0.000877	CbGpPWpGaD
Physostigmine—ACHE—Metabolism—UCP2—type 2 diabetes mellitus	0.0002	0.000877	CbGpPWpGaD
Physostigmine—ACHE—Metabolism—HSD11B1—type 2 diabetes mellitus	0.0002	0.000877	CbGpPWpGaD
Physostigmine—BCHE—Metabolism of proteins—GHRL—type 2 diabetes mellitus	0.000198	0.000872	CbGpPWpGaD
Physostigmine—ACHE—Metabolism of lipids and lipoproteins—APOB—type 2 diabetes mellitus	0.000193	0.00085	CbGpPWpGaD
Physostigmine—BCHE—Metabolism of proteins—ACE—type 2 diabetes mellitus	0.000192	0.000844	CbGpPWpGaD
Physostigmine—BCHE—Metabolism—ABCC8—type 2 diabetes mellitus	0.000191	0.000841	CbGpPWpGaD
Physostigmine—BCHE—Metabolism—CBS—type 2 diabetes mellitus	0.000191	0.000841	CbGpPWpGaD
Physostigmine—ACHE—Metabolism—PCK1—type 2 diabetes mellitus	0.000188	0.000824	CbGpPWpGaD
Physostigmine—ACHE—Metabolism of lipids and lipoproteins—LPL—type 2 diabetes mellitus	0.000185	0.000812	CbGpPWpGaD
Physostigmine—BCHE—Metabolism of proteins—TCF7L2—type 2 diabetes mellitus	0.000185	0.000811	CbGpPWpGaD
Physostigmine—BCHE—Metabolism—COX2—type 2 diabetes mellitus	0.000184	0.00081	CbGpPWpGaD
Physostigmine—BCHE—Metabolism—SLC5A2—type 2 diabetes mellitus	0.000184	0.00081	CbGpPWpGaD
Physostigmine—ACHE—Integrated Pancreatic Cancer Pathway—TGFB1—type 2 diabetes mellitus	0.000184	0.000807	CbGpPWpGaD
Physostigmine—BCHE—Metabolism of proteins—GCG—type 2 diabetes mellitus	0.000181	0.000797	CbGpPWpGaD
Physostigmine—BCHE—Metabolism—NCOA6—type 2 diabetes mellitus	0.000181	0.000796	CbGpPWpGaD
Physostigmine—BCHE—Metabolism of lipids and lipoproteins—PPARGC1A—type 2 diabetes mellitus	0.000181	0.000795	CbGpPWpGaD
Physostigmine—ACHE—Metabolism of lipids and lipoproteins—GPX1—type 2 diabetes mellitus	0.00018	0.000792	CbGpPWpGaD
Physostigmine—ACHE—Integrated Pancreatic Cancer Pathway—EGFR—type 2 diabetes mellitus	0.00018	0.000791	CbGpPWpGaD
Physostigmine—BCHE—Metabolism—HSD11B1—type 2 diabetes mellitus	0.000178	0.000782	CbGpPWpGaD
Physostigmine—BCHE—Metabolism—UCP2—type 2 diabetes mellitus	0.000178	0.000782	CbGpPWpGaD
Physostigmine—BCHE—Metabolism—UCP3—type 2 diabetes mellitus	0.000178	0.000782	CbGpPWpGaD
Physostigmine—ACHE—Metabolism—HK1—type 2 diabetes mellitus	0.000176	0.000772	CbGpPWpGaD
Physostigmine—ACHE—Metabolism of lipids and lipoproteins—CD36—type 2 diabetes mellitus	0.000175	0.000771	CbGpPWpGaD
Physostigmine—ACHE—Metabolism of proteins—GNB3—type 2 diabetes mellitus	0.000175	0.00077	CbGpPWpGaD
Physostigmine—BCHE—Metabolism of lipids and lipoproteins—APOB—type 2 diabetes mellitus	0.000173	0.000758	CbGpPWpGaD
Physostigmine—ACHE—Metabolism of proteins—IGF2—type 2 diabetes mellitus	0.000172	0.000756	CbGpPWpGaD
Physostigmine—ACHE—Integrated Pancreatic Cancer Pathway—TNF—type 2 diabetes mellitus	0.000171	0.000754	CbGpPWpGaD
Physostigmine—ACHE—Metabolism—GCKR—type 2 diabetes mellitus	0.00017	0.000746	CbGpPWpGaD
Physostigmine—ACHE—Metabolism—LPA—type 2 diabetes mellitus	0.00017	0.000746	CbGpPWpGaD
Physostigmine—ACHE—Metabolism—KCNJ11—type 2 diabetes mellitus	0.00017	0.000746	CbGpPWpGaD
Physostigmine—ACHE—Metabolism—HSD3B2—type 2 diabetes mellitus	0.00017	0.000746	CbGpPWpGaD
Physostigmine—BCHE—Metabolism—PCK1—type 2 diabetes mellitus	0.000167	0.000735	CbGpPWpGaD
Physostigmine—BCHE—Metabolism of lipids and lipoproteins—LPL—type 2 diabetes mellitus	0.000165	0.000724	CbGpPWpGaD
Physostigmine—ACHE—Metabolism of lipids and lipoproteins—PPARA—type 2 diabetes mellitus	0.000163	0.000717	CbGpPWpGaD
Physostigmine—ACHE—Metabolism—ALDOB—type 2 diabetes mellitus	0.000163	0.000715	CbGpPWpGaD
Physostigmine—BCHE—Metabolism of lipids and lipoproteins—GPX1—type 2 diabetes mellitus	0.000161	0.000706	CbGpPWpGaD
Physostigmine—ACHE—Metabolism of lipids and lipoproteins—AGT—type 2 diabetes mellitus	0.000158	0.000694	CbGpPWpGaD
Physostigmine—BCHE—Metabolism—HK1—type 2 diabetes mellitus	0.000157	0.000689	CbGpPWpGaD
Physostigmine—BCHE—Metabolism of lipids and lipoproteins—CD36—type 2 diabetes mellitus	0.000157	0.000688	CbGpPWpGaD
Physostigmine—BCHE—Metabolism of proteins—GNB3—type 2 diabetes mellitus	0.000156	0.000687	CbGpPWpGaD
Physostigmine—ACHE—Metabolism of lipids and lipoproteins—APOE—type 2 diabetes mellitus	0.000155	0.00068	CbGpPWpGaD
Physostigmine—BCHE—Metabolism of proteins—IGF2—type 2 diabetes mellitus	0.000154	0.000675	CbGpPWpGaD
Physostigmine—ACHE—Metabolism of lipids and lipoproteins—APOA1—type 2 diabetes mellitus	0.000153	0.000672	CbGpPWpGaD
Physostigmine—BCHE—Metabolism—GCKR—type 2 diabetes mellitus	0.000151	0.000665	CbGpPWpGaD
Physostigmine—BCHE—Metabolism—KCNJ11—type 2 diabetes mellitus	0.000151	0.000665	CbGpPWpGaD
Physostigmine—BCHE—Metabolism—LPA—type 2 diabetes mellitus	0.000151	0.000665	CbGpPWpGaD
Physostigmine—BCHE—Metabolism—HSD3B2—type 2 diabetes mellitus	0.000151	0.000665	CbGpPWpGaD
Physostigmine—ACHE—Metabolism—GLP1R—type 2 diabetes mellitus	0.000151	0.000664	CbGpPWpGaD
Physostigmine—BCHE—Metabolism of lipids and lipoproteins—PPARA—type 2 diabetes mellitus	0.000146	0.00064	CbGpPWpGaD
Physostigmine—BCHE—Metabolism—ALDOB—type 2 diabetes mellitus	0.000145	0.000638	CbGpPWpGaD
Physostigmine—ACHE—Metabolism—SLC2A2—type 2 diabetes mellitus	0.000141	0.00062	CbGpPWpGaD
Physostigmine—BCHE—Metabolism of lipids and lipoproteins—AGT—type 2 diabetes mellitus	0.000141	0.000619	CbGpPWpGaD
Physostigmine—ACHE—Metabolism—MTR—type 2 diabetes mellitus	0.000138	0.000608	CbGpPWpGaD
Physostigmine—ACHE—Metabolism—CPT1A—type 2 diabetes mellitus	0.000138	0.000608	CbGpPWpGaD
Physostigmine—ACHE—Metabolism of proteins—MMP1—type 2 diabetes mellitus	0.000138	0.000607	CbGpPWpGaD
Physostigmine—BCHE—Metabolism of lipids and lipoproteins—APOE—type 2 diabetes mellitus	0.000138	0.000607	CbGpPWpGaD
Physostigmine—BCHE—Metabolism of lipids and lipoproteins—APOA1—type 2 diabetes mellitus	0.000136	0.0006	CbGpPWpGaD
Physostigmine—ACHE—Metabolism of proteins—AGT—type 2 diabetes mellitus	0.000136	0.0006	CbGpPWpGaD
Physostigmine—ACHE—Metabolism—NAMPT—type 2 diabetes mellitus	0.000136	0.000596	CbGpPWpGaD
Physostigmine—BCHE—Metabolism—GLP1R—type 2 diabetes mellitus	0.000135	0.000593	CbGpPWpGaD
Physostigmine—ACHE—Metabolism of lipids and lipoproteins—PPARG—type 2 diabetes mellitus	0.000135	0.000593	CbGpPWpGaD
Physostigmine—ACHE—Metabolism—LIPC—type 2 diabetes mellitus	0.000135	0.000592	CbGpPWpGaD
Physostigmine—ACHE—Metabolism—HBA1—type 2 diabetes mellitus	0.000135	0.000592	CbGpPWpGaD
Physostigmine—ACHE—Metabolism—GCK—type 2 diabetes mellitus	0.000135	0.000592	CbGpPWpGaD
Physostigmine—ACHE—Metabolism—CYP11A1—type 2 diabetes mellitus	0.000134	0.000589	CbGpPWpGaD
Physostigmine—ACHE—Metabolism of proteins—LEP—type 2 diabetes mellitus	0.000134	0.000588	CbGpPWpGaD
Physostigmine—ACHE—Metabolism—SLC9A1—type 2 diabetes mellitus	0.000132	0.000578	CbGpPWpGaD
Physostigmine—ACHE—Metabolism—CETP—type 2 diabetes mellitus	0.00013	0.000571	CbGpPWpGaD
Physostigmine—ACHE—Integrated Pancreatic Cancer Pathway—AKT1—type 2 diabetes mellitus	0.000128	0.000561	CbGpPWpGaD
Physostigmine—BCHE—Metabolism—SLC2A2—type 2 diabetes mellitus	0.000126	0.000553	CbGpPWpGaD
Physostigmine—BCHE—Metabolism—MTR—type 2 diabetes mellitus	0.000123	0.000542	CbGpPWpGaD
Physostigmine—BCHE—Metabolism—CPT1A—type 2 diabetes mellitus	0.000123	0.000542	CbGpPWpGaD
Physostigmine—BCHE—Metabolism of proteins—MMP1—type 2 diabetes mellitus	0.000123	0.000542	CbGpPWpGaD
Physostigmine—BCHE—Metabolism of proteins—AGT—type 2 diabetes mellitus	0.000122	0.000535	CbGpPWpGaD
Physostigmine—ACHE—Metabolism of lipids and lipoproteins—ALB—type 2 diabetes mellitus	0.000121	0.000533	CbGpPWpGaD
Physostigmine—BCHE—Metabolism—NAMPT—type 2 diabetes mellitus	0.000121	0.000532	CbGpPWpGaD
Physostigmine—ACHE—Metabolism—SREBF1—type 2 diabetes mellitus	0.000121	0.000531	CbGpPWpGaD
Physostigmine—ACHE—Metabolism—PSMD6—type 2 diabetes mellitus	0.000121	0.000531	CbGpPWpGaD
Physostigmine—ACHE—Metabolism—SNAP25—type 2 diabetes mellitus	0.000121	0.000531	CbGpPWpGaD
Physostigmine—BCHE—Metabolism of lipids and lipoproteins—PPARG—type 2 diabetes mellitus	0.00012	0.000529	CbGpPWpGaD
Physostigmine—BCHE—Metabolism—GCK—type 2 diabetes mellitus	0.00012	0.000528	CbGpPWpGaD
Physostigmine—BCHE—Metabolism—LIPC—type 2 diabetes mellitus	0.00012	0.000528	CbGpPWpGaD
Physostigmine—BCHE—Metabolism—HBA1—type 2 diabetes mellitus	0.00012	0.000528	CbGpPWpGaD
Physostigmine—BCHE—Metabolism—CYP11A1—type 2 diabetes mellitus	0.000119	0.000525	CbGpPWpGaD
Physostigmine—BCHE—Metabolism of proteins—LEP—type 2 diabetes mellitus	0.000119	0.000524	CbGpPWpGaD
Physostigmine—ACHE—Metabolism—CTGF—type 2 diabetes mellitus	0.000119	0.000521	CbGpPWpGaD
Physostigmine—ACHE—Metabolism—HMGCR—type 2 diabetes mellitus	0.000118	0.000517	CbGpPWpGaD
Physostigmine—BCHE—Metabolism—SLC9A1—type 2 diabetes mellitus	0.000117	0.000516	CbGpPWpGaD
Physostigmine—BCHE—Metabolism—CETP—type 2 diabetes mellitus	0.000116	0.00051	CbGpPWpGaD
Physostigmine—ACHE—Metabolism of lipids and lipoproteins—PIK3R1—type 2 diabetes mellitus	0.000116	0.00051	CbGpPWpGaD
Physostigmine—ACHE—Metabolism—ADRA2A—type 2 diabetes mellitus	0.000115	0.000506	CbGpPWpGaD
Physostigmine—ACHE—Metabolism of proteins—INS—type 2 diabetes mellitus	0.000114	0.000502	CbGpPWpGaD
Physostigmine—ACHE—Metabolism of proteins—CCL2—type 2 diabetes mellitus	0.000112	0.000494	CbGpPWpGaD
Physostigmine—ACHE—Metabolism—CYP2E1—type 2 diabetes mellitus	0.000111	0.000486	CbGpPWpGaD
Physostigmine—ACHE—Metabolism of proteins—IGF1—type 2 diabetes mellitus	0.000111	0.000486	CbGpPWpGaD
Physostigmine—ACHE—Metabolism—SLC2A1—type 2 diabetes mellitus	0.000109	0.00048	CbGpPWpGaD
Physostigmine—ACHE—Metabolism—CYP1A2—type 2 diabetes mellitus	0.000109	0.00048	CbGpPWpGaD
Physostigmine—BCHE—Metabolism of lipids and lipoproteins—ALB—type 2 diabetes mellitus	0.000108	0.000475	CbGpPWpGaD
Physostigmine—BCHE—Metabolism—SREBF1—type 2 diabetes mellitus	0.000108	0.000474	CbGpPWpGaD
Physostigmine—BCHE—Metabolism—PSMD6—type 2 diabetes mellitus	0.000108	0.000474	CbGpPWpGaD
Physostigmine—BCHE—Metabolism—SNAP25—type 2 diabetes mellitus	0.000108	0.000474	CbGpPWpGaD
Physostigmine—ACHE—Metabolism—CYP3A4—type 2 diabetes mellitus	0.000107	0.000468	CbGpPWpGaD
Physostigmine—ACHE—Metabolism of lipids and lipoproteins—PTGS2—type 2 diabetes mellitus	0.000106	0.000466	CbGpPWpGaD
Physostigmine—BCHE—Metabolism—CTGF—type 2 diabetes mellitus	0.000106	0.000465	CbGpPWpGaD
Physostigmine—BCHE—Metabolism—HMGCR—type 2 diabetes mellitus	0.000105	0.000461	CbGpPWpGaD
Physostigmine—ACHE—Metabolism—SLC2A4—type 2 diabetes mellitus	0.000105	0.000461	CbGpPWpGaD
Physostigmine—ACHE—Metabolism—GCG—type 2 diabetes mellitus	0.000105	0.000461	CbGpPWpGaD
Physostigmine—BCHE—Metabolism of lipids and lipoproteins—PIK3R1—type 2 diabetes mellitus	0.000103	0.000455	CbGpPWpGaD
Physostigmine—BCHE—Metabolism—ADRA2A—type 2 diabetes mellitus	0.000103	0.000451	CbGpPWpGaD
Physostigmine—BCHE—Metabolism of proteins—INS—type 2 diabetes mellitus	0.000102	0.000448	CbGpPWpGaD
Physostigmine—BCHE—Metabolism of proteins—CCL2—type 2 diabetes mellitus	0.0001	0.000441	CbGpPWpGaD
Physostigmine—BCHE—Metabolism—CYP2E1—type 2 diabetes mellitus	9.86e-05	0.000433	CbGpPWpGaD
Physostigmine—BCHE—Metabolism of proteins—IGF1—type 2 diabetes mellitus	9.86e-05	0.000433	CbGpPWpGaD
Physostigmine—BCHE—Metabolism—SLC2A1—type 2 diabetes mellitus	9.75e-05	0.000429	CbGpPWpGaD
Physostigmine—BCHE—Metabolism—CYP1A2—type 2 diabetes mellitus	9.75e-05	0.000429	CbGpPWpGaD
Physostigmine—BCHE—Metabolism—CYP3A4—type 2 diabetes mellitus	9.51e-05	0.000418	CbGpPWpGaD
Physostigmine—BCHE—Metabolism of lipids and lipoproteins—PTGS2—type 2 diabetes mellitus	9.46e-05	0.000416	CbGpPWpGaD
Physostigmine—BCHE—Metabolism—SLC2A4—type 2 diabetes mellitus	9.35e-05	0.000411	CbGpPWpGaD
Physostigmine—BCHE—Metabolism—GCG—type 2 diabetes mellitus	9.35e-05	0.000411	CbGpPWpGaD
Physostigmine—ACHE—Metabolism—PPARGC1A—type 2 diabetes mellitus	9.03e-05	0.000397	CbGpPWpGaD
Physostigmine—ACHE—Metabolism—GNB3—type 2 diabetes mellitus	9.03e-05	0.000397	CbGpPWpGaD
Physostigmine—ACHE—Metabolism—HMOX1—type 2 diabetes mellitus	8.99e-05	0.000395	CbGpPWpGaD
Physostigmine—ACHE—Metabolism—CAT—type 2 diabetes mellitus	8.87e-05	0.00039	CbGpPWpGaD
Physostigmine—ACHE—Metabolism—APOB—type 2 diabetes mellitus	8.61e-05	0.000379	CbGpPWpGaD
Physostigmine—ACHE—Metabolism—GSTM1—type 2 diabetes mellitus	8.38e-05	0.000368	CbGpPWpGaD
Physostigmine—ACHE—Metabolism—LPL—type 2 diabetes mellitus	8.22e-05	0.000361	CbGpPWpGaD
Physostigmine—BCHE—Metabolism—GNB3—type 2 diabetes mellitus	8.06e-05	0.000354	CbGpPWpGaD
Physostigmine—BCHE—Metabolism—PPARGC1A—type 2 diabetes mellitus	8.06e-05	0.000354	CbGpPWpGaD
Physostigmine—ACHE—Metabolism—ADCY5—type 2 diabetes mellitus	8.05e-05	0.000354	CbGpPWpGaD
Physostigmine—ACHE—Metabolism—GPX1—type 2 diabetes mellitus	8.02e-05	0.000353	CbGpPWpGaD
Physostigmine—BCHE—Metabolism—HMOX1—type 2 diabetes mellitus	8.02e-05	0.000353	CbGpPWpGaD
Physostigmine—BCHE—Metabolism—CAT—type 2 diabetes mellitus	7.91e-05	0.000348	CbGpPWpGaD
Physostigmine—ACHE—Metabolism—CD36—type 2 diabetes mellitus	7.81e-05	0.000343	CbGpPWpGaD
Physostigmine—ACHE—Metabolism—PPP2CA—type 2 diabetes mellitus	7.72e-05	0.000339	CbGpPWpGaD
Physostigmine—BCHE—Metabolism—APOB—type 2 diabetes mellitus	7.68e-05	0.000338	CbGpPWpGaD
Physostigmine—BCHE—Metabolism—GSTM1—type 2 diabetes mellitus	7.47e-05	0.000328	CbGpPWpGaD
Physostigmine—ACHE—Metabolism—MTHFR—type 2 diabetes mellitus	7.4e-05	0.000325	CbGpPWpGaD
Physostigmine—BCHE—Metabolism—LPL—type 2 diabetes mellitus	7.34e-05	0.000322	CbGpPWpGaD
Physostigmine—ACHE—Metabolism—PPARA—type 2 diabetes mellitus	7.26e-05	0.000319	CbGpPWpGaD
Physostigmine—BCHE—Metabolism—ADCY5—type 2 diabetes mellitus	7.18e-05	0.000316	CbGpPWpGaD
Physostigmine—BCHE—Metabolism—GPX1—type 2 diabetes mellitus	7.16e-05	0.000315	CbGpPWpGaD
Physostigmine—ACHE—Metabolism—AGT—type 2 diabetes mellitus	7.04e-05	0.000309	CbGpPWpGaD
Physostigmine—BCHE—Metabolism—CD36—type 2 diabetes mellitus	6.97e-05	0.000306	CbGpPWpGaD
Physostigmine—ACHE—Metabolism—CALM1—type 2 diabetes mellitus	6.92e-05	0.000304	CbGpPWpGaD
Physostigmine—ACHE—Metabolism—APOE—type 2 diabetes mellitus	6.89e-05	0.000303	CbGpPWpGaD
Physostigmine—BCHE—Metabolism—PPP2CA—type 2 diabetes mellitus	6.88e-05	0.000303	CbGpPWpGaD
Physostigmine—ACHE—Metabolism—APOA1—type 2 diabetes mellitus	6.81e-05	0.000299	CbGpPWpGaD
Physostigmine—BCHE—Metabolism—MTHFR—type 2 diabetes mellitus	6.61e-05	0.00029	CbGpPWpGaD
Physostigmine—BCHE—Metabolism—PPARA—type 2 diabetes mellitus	6.48e-05	0.000285	CbGpPWpGaD
Physostigmine—BCHE—Metabolism—AGT—type 2 diabetes mellitus	6.28e-05	0.000276	CbGpPWpGaD
Physostigmine—BCHE—Metabolism—CALM1—type 2 diabetes mellitus	6.17e-05	0.000271	CbGpPWpGaD
Physostigmine—BCHE—Metabolism—APOE—type 2 diabetes mellitus	6.15e-05	0.00027	CbGpPWpGaD
Physostigmine—BCHE—Metabolism—APOA1—type 2 diabetes mellitus	6.08e-05	0.000267	CbGpPWpGaD
Physostigmine—ACHE—Metabolism—PPARG—type 2 diabetes mellitus	6e-05	0.000264	CbGpPWpGaD
Physostigmine—ACHE—Metabolism—INS—type 2 diabetes mellitus	5.89e-05	0.000259	CbGpPWpGaD
Physostigmine—ACHE—Metabolism—ALB—type 2 diabetes mellitus	5.4e-05	0.000237	CbGpPWpGaD
Physostigmine—BCHE—Metabolism—PPARG—type 2 diabetes mellitus	5.36e-05	0.000235	CbGpPWpGaD
Physostigmine—BCHE—Metabolism—INS—type 2 diabetes mellitus	5.25e-05	0.000231	CbGpPWpGaD
Physostigmine—ACHE—Metabolism—NOS3—type 2 diabetes mellitus	5.16e-05	0.000227	CbGpPWpGaD
Physostigmine—ACHE—Metabolism—PIK3R1—type 2 diabetes mellitus	5.16e-05	0.000227	CbGpPWpGaD
Physostigmine—BCHE—Metabolism—ALB—type 2 diabetes mellitus	4.82e-05	0.000212	CbGpPWpGaD
Physostigmine—ACHE—Metabolism—PTGS2—type 2 diabetes mellitus	4.72e-05	0.000208	CbGpPWpGaD
Physostigmine—BCHE—Metabolism—PIK3R1—type 2 diabetes mellitus	4.61e-05	0.000202	CbGpPWpGaD
Physostigmine—BCHE—Metabolism—NOS3—type 2 diabetes mellitus	4.61e-05	0.000202	CbGpPWpGaD
Physostigmine—BCHE—Metabolism—PTGS2—type 2 diabetes mellitus	4.21e-05	0.000185	CbGpPWpGaD
Physostigmine—ACHE—Metabolism—AKT1—type 2 diabetes mellitus	2.37e-05	0.000104	CbGpPWpGaD
Physostigmine—BCHE—Metabolism—AKT1—type 2 diabetes mellitus	2.12e-05	9.31e-05	CbGpPWpGaD
